Niwa R, Sakai K*, Lung MSY, Matsumoto T, Mikawa R, Maehana S, Suzuki M, Yamamoto Y, Maurissen TL, Hirabayashi A, Noda T, Kubo M, Gotoh S*, Woltjen K*.
ACE2 knockout hinders SARS-CoV-2 propagation in iPS cell-derived airway and alveolar epithelial cells. Front Cell Dev Biol, 2023 Dec 8; 11: 1290876.

Yadav S, Fujimoto K, Takenaga T, Takahashi S, Muramoto Y, Mikawa R, Noda T, Gotoh S, Yokokawa R*.
Isogenic iPSC-derived proximal and distal lung-on-chip models: Tissue and virus-specific immune responses in human lungs. bioRxiv. 2023 Nov 24.

Hosokawa M, Mikawa R, Hagiwara A, Okuno Y, Awaya T, Yamamoto Y, Takahashi S, Yamaki H, Osawa M, Setoguchi Y, Saito MK, Abe S, Hirai T, Gotoh S*, Hagiwara M*.
Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC. iScience, 2023 Oct; 26(10): 107731.

Li R, Sone N, Gotoh S, Sun X, Hagood JS*.
Contemporary and emerging technologies for research in children's rare and interstitial lung disease. Pediatr Pulmonol. 2023 May 19; Epub ahead of print.

Muramoto Y, Takahashi S, Halfmann PJ, Gotoh S, Noda T*, Kawaoka Y*.
Replicative capacity of SARS-CoV-2 omicron variants BA.5 and BQ.1.1 at elevated temperatures. Lancet Microbe. 2023 Jul;4(7): e486.

Xu Y, Feng G, Yano T, Masuda S, Nagao M, Gotoh S, Ikejiri M, Tanabe M, Takeuchi K.
Characteristic genetic spectrum of primary ciliary dyskinesia in Japanese patients and global ethnic heterogeneity: population-based genomic variation database analysis. J Hum Genet. 2023 Jul; 68(7): 455-461.